Venovenous extracorporeal membrane oxygenation (VV ECMO) has become an essential yet resource-intensive intervention for patients with severe, refractory respiratory failure. Despite its growing use in critical care medicine, there remains a lack of standardized criteria for determining which patients should receive this therapy. The study titled Clinician Perspectives on the Extracorporeal Membrane Oxygenation Decision-Making Process provides an in-depth qualitative analysis of how clinicians navigate these complex decisions in real-world settings.
Conducted between September and December 2024, this study involved semi-structured interviews with 24 clinicians, including physicians and ECMO coordinators from nine countries. As shown in the participant table on page 3, the cohort represented a range of experience levels, institutional types, and geographic backgrounds, offering a broad perspective on ECMO decision-making. The researchers used thematic analysis to identify patterns in how clinicians assess patient candidacy.
One of the most significant findings is the variability in how clinicians interpret key clinical variables such as age, body mass index (BMI), and duration of mechanical ventilation. While these factors are commonly used, they are often treated as flexible guidelines rather than strict thresholds. For example, age cutoffs ranged widely from 60 to 80 years, with many clinicians emphasizing “physiologic age” over chronological age. Similarly, BMI was frequently considered in terms of technical feasibility—such as vascular access—rather than as a strict exclusion criterion. Time on mechanical ventilation, often cited as a cutoff between 7 and 14 days, was interpreted variably depending on perceived reversibility of lung injury.
Beyond these clinical factors, the study highlights the importance of social and ethical considerations in ECMO candidacy decisions. Clinicians frequently evaluated patients’ quality of life, functional status, and social support systems. As noted in the quotations on page 5, decisions were influenced by whether a patient could realistically recover to a meaningful quality of life or adhere to long-term care requirements. Patient autonomy also played a critical role, with many clinicians respecting prior wishes regarding life-sustaining treatments.
A particularly important contribution of this study is its identification of cognitive biases that influence decision-making. As detailed in Table 3 on page 7, biases such as loss aversion, recency bias, and sunk cost bias were commonly reported. For instance, clinicians were more likely to pursue ECMO in younger patients despite unfavorable clinical factors, reflecting an emotional reluctance to “give up” on those perceived to have more life ahead. Similarly, recent clinical experiences often shaped current decisions, even when not directly applicable. These findings underscore the human element inherent in high-stakes medical decision-making.
Institutional and cultural factors also played a significant role. Resource availability, including ECMO circuits, ICU beds, and staffing, directly influenced candidacy decisions. During periods of high demand, such as surges, clinicians reported stricter selection criteria. Additionally, the presence or absence of a transplant program affected whether ECMO was considered a viable bridge to recovery or transplantation. Team dynamics further contributed to variability, with decisions often shaped by hierarchy, consensus processes, and the specific clinicians involved at a given time.
Importantly, all participants acknowledged inconsistencies in ECMO allocation and expressed a desire for improved standardization. Suggestions for improvement, summarized in Table 4 on page 8, included developing clearer evidence-based guidelines, standardizing team decision-making processes, and increasing transparency through case reviews and outcome tracking. These strategies aim to balance the need for individualized clinical judgment with the goal of equitable resource allocation.
The study also raises broader ethical concerns about fairness and equity in critical care. Previous research has shown disparities in ECMO utilization based on factors such as race, socioeconomic status, and geographic location. By revealing the subjective and context-dependent nature of candidacy decisions, this study highlights how variability may contribute to these disparities.
In conclusion, this research provides valuable insight into the nuanced and multifactorial process of ECMO decision-making. While flexibility is necessary in a complex and evolving field, the lack of standardized criteria introduces variability that may affect patient outcomes and equity. The findings emphasize the need for structured frameworks that incorporate clinical evidence, ethical principles, and institutional considerations. As ECMO continues to expand in use, improving consistency and transparency in patient selection will be critical to ensuring fair and effective care.
